|
Selection
|
Rank
|
Recall
|
Precision
|
F-score
|
|---|
|
Baseline: Genes / Proteins
|
60
|
0.10
|
0.92
|
0.17
|
| |
230
|
0.30
|
0.73
|
0.42
|
| |
469
|
0.50
|
0.61
|
0.55
|
|
Maximal F-score
|
728
|
0.67
|
0.52
|
0.59
|
|
Baseline + Clinical Management
|
61
|
0.10
|
0.90
|
0.17
|
| |
226
|
0.30
|
0.75
|
0.42
|
| |
465
|
0.50
|
0.61
|
0.55
|
|
Maximal F-score
|
682
|
0.65
|
0.54
|
0.59
|
|
Baseline + Evidence Marker
|
62
|
0.10
|
0.89
|
0.17
|
| |
225
|
0.30
|
0.75
|
0.42
|
| |
464
|
0.50
|
0.61
|
0.55
|
|
Maximal F-score
|
654
|
0.62
|
0.54
|
0.57
|
|
Baseline +Prognosis
|
63
|
0.10
|
0.87
|
0.17
|
| |
247
|
0.30
|
0.68
|
0.41
|
| |
541
|
0.50
|
0.52
|
0.51
|
|
Maximal F-score
|
740
|
0.61
|
0.47
|
0.53
|
|
Baseline + Diagnostics
|
64
|
0.10
|
0.86
|
0.17
|
| |
237
|
0.30
|
0.71
|
0.42
|
| |
494
|
0.50
|
0.57
|
0.53
|
|
Maximal F-score
|
520
|
0.52
|
0.57
|
0.54
|
|
Baseline + Statistics
|
64
|
0.10
|
0.86
|
0.17
|
| |
227
|
0.30
|
0.74
|
0.42
|
| |
678
|
0.50
|
0.42
|
0.45
|
|
Maximal F-score
|
377
|
0.41
|
0.62
|
0.49
|
|
Baseline + Clinical Management + Evidence Marker
|
60
|
0.10
|
0.92
|
0.17
|
| |
224
|
0.30
|
0.75
|
0.42
|
| |
451
|
0.50
|
0.63
|
0.56
|
|
Maximal F-score
|
555
|
0.57
|
0.59
|
0.58
|
|
Baseline + Clinical Management + Evidence Marker + Prognosis
|
61
|
0.10
|
0.90
|
0.17
|
| |
230
|
0.30
|
0.73
|
0.42
|
| |
568
|
0.50
|
0.50
|
0.50
|
|
Maximal F-score
|
479
|
0.47
|
0.56
|
0.51
|
- Genes were ranked based on frequency and evaluated against the Alzheimer’s gold standard. For the different selections recall, precision, F-score and rank has been estimated for 10, 30, and 50% recall. In addition the maximal recall has been estimated.
